US FDA Discourages Off-Label Guidance Suits as Challenges To Entire Approval Authority

 
• By Michael McCaughan
  
The FDA said BIO/PhRMA marketing principles were not as specific as its policy. (Shutterstock)

More from Marketing & Advertising

More from Legal & IP